TUG1 promoted SIX1 expression, increasing glycolysis and metastasis in HCC cells by interacting with miR-524–5p (Lu et al., 2022a) and activated the JAK/STAT3 pathway by targeting miR-144 (Lv et al., 2018). Here, STAT3 is linked to hepatocellular carcinoma.